13F data as of 2021-12-31 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/NVACU

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

No Form 8-K filings for this ticker

CUSIP

66718N202

FAQ

Who are the top institutional investors holding NORTHVIEW ACQUISITION CORP (NVACU)?

Major stakeholders currently include Saba Capital Management, L.P. ($11.7M), Yakira Capital Management, Inc. ($10.0M), Boothbay Fund Management, LLC ($9.0M). Based on the latest 13F filings, there are a total of 46 tracked investment funds and institutions maintaining positions in NVACU.

What is the overall institutional sentiment toward NVACU recently?

Institutional sentiment appears Bullish (Net Buying). During the most recent reporting quarter, the stock experienced a net inflow of $155.0M, driven by 12 managers accumulating shares while 0 reduced their exposure.

Which institutions have been selling or reducing their NVACU positions?

In the latest period, no tracked funds trimmed or exited their positions in NVACU.

Are there any notable investors adding NVACU to their portfolios?

Yes, buying activity remains notable. 12 institutions opened new positions in {ticker}, and 0 existing holders added to their shares. The total reported buy value for the quarter amounted to $41.8M.